ADHD Diagnosis and Treatment: Major Barriers in Australia
- DASA
- Oct 27
- 2 min read
According to a recent SBS News article, there is growing awareness of ADHD in Australia, especially among adults, but there are also significant challenges in getting diagnosed and treated. Despite increased public understanding, the healthcare system is struggling to keep up with demand.
One of the biggest hurdles is access to diagnosis. Many Australians wait up to 18 months for specialist appointments, and private assessments can cost over $1,000, making diagnosis unaffordable for many. ADHD is not fully covered by Medicare, and public services are limited, especially for adults. This leaves many people undiagnosed or forced to seek costly private care.
The article also points out that ADHD is often misunderstood, particularly in adults and women.
Historically seen as a childhood condition affecting mostly boys, ADHD in women is frequently overlooked or misdiagnosed. This contributes to delays in treatment and emotional distress.
Once diagnosed, treatment options, primarily medication and therapy, can be effective. However, access to therapy is also limited, and medication alone may not address all symptoms. The lack of integrated care and support services means many individuals struggle to manage their condition long-term.
Advocates and experts interviewed in the article call for systemic reform, including better funding, streamlined diagnostic pathways, and broader education for health professionals and the public. They stress that ADHD is a legitimate medical condition, not a behavioural issue, and that timely diagnosis and support can dramatically improve quality of life.
In short, while awareness of ADHD is rising, Australia’s healthcare system faces major gaps in providing timely, affordable, and comprehensive care, especially for adults, women, and those in disadvantaged communities.
Understanding ADHD and the impact of the associated medications in the workplace is complex but necessary. Our experts at DASA can assist your organisation navigate these issues. Contact us on 1300 230 231 to know more.
Want to learn more about ADHD and how it affects the workplace?
Join Associate Professor David Allen at 11am on Wednesday 12th November for our free webinar “Stimulants, Amphetamines, ADHD, Autism, Tylenol and Other Controversies: Implications for Workplaces and the Community”. Whether you're an employer, safety manager, or someone navigating ADHD personally, this session will offer valuable insights.
DASA (Drug and Alcohol Solutions Australia) is proud to be leading the way in workplace drug and alcohol testing services throughout Australia. Whether your need is for workplace drug and workplace alcohol testing, advice on drug and alcohol policy or ideas on how to communicate your workplace expectations, policies and procedures to your staff, DASA can help. We have the experience, technical expertise and people to lead you to the right solution.
Comments